AB Science a reçu l’autorisation de l’ANSM pour initier une étude de Phase II chez les patients atteints du syndrome d’activation des mastocytes sévère
January 19, 2022 12:02 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE A RECU L’AUTORISATION DE L’ANSM POUR INITIER UNE ETUDE DE PHASE II CHEZ LES PATIENTS ATTEINTS DU SYNDROME D’ACTIVATION DES MASTOCYTES SEVERE Paris, 19 janvier 2022,...
AB Science has been granted authorization to initiate Phase II study in patients with severe mast cell activation syndrome by the French Health Authority (ANSM)
January 19, 2022 12:02 ET
|
AB Science
PRESS RELEASE AB SCIENCE HAS BEEN GRANTED AUTHORIZATION TO INITIATE PHASE II STUDY IN PATIENTS WITH SEVERE MAST CELL ACTIVATION SYNDROME BY THE FRENCH HEALTH AUTHORITY (ANSM) Paris, 19 January,...
AB Science reçoit l’autorisation de la FDA pour initier le programme de développement clinique du masitinib dans le syndrome d’activation des mastocytes (MCAS)
October 04, 2021 12:10 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT L'AUTORISATION DE LA FOOD AND DRUG ADMINISTRATION (FDA) AMÉRICAINE POUR INITIER LE PROGRAMME DE DÉVELOPPEMENT CLINIQUE DU MASITINIB DANS LE SYNDROME...
AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS)
October 04, 2021 12:10 ET
|
AB Science
PRESS RELEASE AB SCIENCE RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) AUTHORIZATION TO START CLINICAL DEVELOPMENT PROGRAM OF MASITINIB IN MAST CELL ACTIVATION SYNDROME (MCAS) MCAS IS A...
U.S. Marine Corps Seeks Catholic Coordinator in Beaufort
October 10, 2017 15:00 ET
|
US Federal Contractor Registration
Beaufort, South Carolina, Oct. 10, 2017 (GLOBE NEWSWIRE) -- The U.S. Department of the Navy, U.S. Marine Corps, for the Marine Corps Air Station (MCAS) in Beaufort, South Carolina released a...